Skip to Content
  • 1.6
    Impact Factor
  • 17 days
    Time to First Decision

Women

Women is an international, peer-reviewed, open access journal on women's medicine and healthcare published quarterly online by MDPI. 

Quartile Ranking JCR - Q2 (Womens Studies)

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (209)

  • Brief Report
  • Open Access

Combined oral contraceptive pills (COCPs) are commonly used by reproductive-aged women with overweight or obesity, but their metabolic effects remain understudied. This pilot study examined the feasibility of recruiting and retaining women with overweight or obesity initiating COCPs and evaluated changes in body weight, body composition, energy intake (EI), eating behaviors, and cardiometabolic markers. Premenopausal women aged 18–40 years with a body mass index between 25 and 45 kg/m2 initiating COCPs (n = 10) or using nonhormonal contraception (NHC; n = 10) were followed for six months. Outcome measures included body weight, body composition, EI, eating behavior questionnaires, ecological momentary assessment of appetite and satiety, and fasting laboratory measures. There were no between-group differences in changes in weight, EI, or appetite. Binge-eating severity decreased in COCP users and increased in NHC users, though the within-group change in COCP users was not statistically significant. Exploratory analyses demonstrated increases in hemoglobin A1c and triglycerides among COCP users compared to NHC users, while bioavailable testosterone decreased in COCP users only. This study demonstrates high retention and feasibility among women with overweight/obesity undergoing intensive dietary and metabolic monitoring. Although weight outcomes were similar between groups, these preliminary findings identify potential metabolic signals warranting confirmation in adequately powered studies.

4 March 2026

Flow diagram of participant recruitment and retention in premenopausal women with overweight/obesity using COCPs vs. NHCs at CU-AMC (November 2021–June 2023). Women were eligible for inclusion if they were 18–40 years old, had a BMI between 25 and 45 kg/m2, and were free of major medical or psychiatric illnesses. Women were excluded if they had metabolic or endocrine disorders (i.e., diabetes, polycystic ovary syndrome, congenital adrenal hyperplasia), a history of weight loss surgery, used medications affecting body weight (i.e., systemic glucocorticoids, stimulants, weight loss pharmacotherapy, metformin), current tobacco use, recent pregnancy-related events (i.e., current or planned pregnancy, abortion, miscarriage, or delivery), lactation, current or anticipated enrollment in a weight management program or research study with a dietary or physical activity component, or planned major dietary or physical activity changes. a Of the 38 women who were eligible for participation, 23 (61%) provided written consent. The remaining 15 women either did not respond to additional outreach attempts (n = 8), declined participation after screening (n = 6), or completed screening after the recruitment period ended (n = 1). b Among 68 women who were not eligible, the primary reasons for exclusion included BMI too low (n = 41), BMI too high (n = 1), current or recent (<3 m) hormonal contraception use (n = 19), breastfeeding (n = 1), weight loss surgery within the last year (n = 1), use of medications potentially influencing weight (n = 2), heavy smoking (n = 1), or current enrollment in a weight management program or research study (n = 2). c Three women who consented did not complete baseline measures and were lost to follow-up prior to data collection. Those who were not using hormonal contraceptives and elected to start the norgestimate/ethinyl estradiol 0.25 mg/35 mcg COCP after a contraceptive counseling visit were enrolled in the COCP group. Women who chose to continue using NHCs (i.e., the copper intrauterine device, male condoms, tubal ligation, partner vasectomy, withdrawal, natural family planning, abstinence, etc.) were included in the NHC group. d One participant did not complete 6-month measures in the COCP group and withdrew from the study due to worsening mental health after initiating the norgestimate/ethinyl estradiol 0.25 mg/35 mcg pill. Created in BioRender. Zaman, A. (2026) https://BioRender.com/a21jj54 (accessed on 27 February 2026).

Evolution, Distribution and Prediction of Cervical Cancer Mortality in a Central Mexican State Using a Dynamic Model

  • Yolanda Terán-Figueroa,
  • Darío Gaytán-Hernández and
  • Efraín Gaytán-Jiménez
  • + 3 authors

This study analyzes the evolution and spatial distribution of cervical cancer mortality. Furthermore, it develops a dynamic simulation model for estimating the evolution of the disease up to 2040. This manuscript details an ecological and retrospective study that analyzed official mortality, morbidity, and population data from the 58 municipalities that constitute the state of San Luis Potosi. We used Moran’s index, linear correlation, structural equation modeling, Excel predictions, and Vensim PLE x64 simulation software to conduct this study. The evolution of deaths from cervical cancer shows a downward trend; mortality follows a clustered distribution pattern, and it is not random. The structural model showed standardized regression coefficients of 0.68 between syphilis cases and cervical cancer cases, with a coefficient of 0.35 for deaths; candidiasis cases with cervical cancer at a coefficient of 0.25 and with deaths from the same disease at a coefficient of 0.46. The coefficients of determination for cervical cancer cases and deaths were 0.74 and 0.91, respectively. This shows that these co-infections—syphilis and candidiasis—are a risk factor for cervical cancer mortality. The estimated mortality rates per 100,000 inhabitants for 2025, 2030, 2035, and 2040 were 5.5, 5.1, 4.8, and 4.4, respectively. The prediction indicates an increase in the number of CC cases and deaths from this cause.

2 March 2026

Evolution of CC mortality rates in the period 1979–2023 in the State of San Luis Potosí, Mexico. The dotted line indicates the trend, and the solid line indicates the observed rates.

Metacognitive Dysfunction in Women with Eating Disorders: A Narrative Review

  • Fabiola Raffone,
  • Serena Testa and
  • Vassilis Martiadis
  • + 5 authors

Eating disorders (EDs) disproportionately affect women and are associated with substantial morbidity, chronicity, and mortality. While established psychological models focus on the content of maladaptive cognitions related to body weight, shape, and eating behaviors, growing evidence suggests that additional process-level mechanisms contribute to symptom persistence and treatment resistance. Metacognitive models emphasize how individuals relate to their thoughts, emotions, and internal experiences, highlighting maladaptive beliefs about thinking and the resulting cognitive–attentional patterns (e.g., repetitive negative thinking, self-focused attention, and inflexible attentional control) as potential maintaining factors across psychopathology. This narrative review synthesizes the theoretical and empirical literature on metacognitive dysfunction in EDs, with a focus on mechanisms that may be particularly relevant for women. We integrate epidemiological data and gender-sensitive frameworks, and review evidence on metacognitive beliefs and cognitive–attentional syndrome (CAS)-related processes across anorexia nervosa, bulimia nervosa, and binge-eating disorder. Overall, studies indicate that dysfunctional beliefs about the uncontrollability and danger of thoughts, alongside perseverative cognitive styles, are associated with greater ED symptom severity. We discuss diagnosis-relevant patterns as clinically useful heuristics, interactions with sociocultural and emotional vulnerability factors, and implications for assessment, treatment integration, and prevention. The evidence base is largely correlational and derived from predominantly female samples, underscoring the need for longitudinal research and studies that explicitly test sex/gender as a moderator.

2 March 2026

Conceptual framework illustrating hypothesized relationships between sociocultural influences (e.g., objectification/self-surveillance), metacognitive beliefs (e.g., beliefs about uncontrollability/danger and need for control), and CAS-related cognitive–attentional processes (e.g., worry/rumination, self-focused monitoring, rigid control strategies) that are associated with eating disorder psychopathology. Self-evaluative emotions (e.g., guilt/shame) are shown as potential triggers/modulators. The model is intended as hypothesis-generating and does not imply definitive causal pathways or diagnosis-specific profiles.

Body Dissatisfaction and Eating Disorder Risk Indicators in Older Women: Associations with Medically Supervised Dietary Treatment

  • Patrizia Carmen Marruffi-Bonfante,
  • Manuel Rosety-Rodríguez and
  • Javier Riscart-López
  • + 2 authors

Body dissatisfaction and eating disorder (ED) risk indicators can persist into later life but are less frequently assessed in routine care for older women. Among women aged 50 years and older, attendance on dietary care pathways in clinical settings may offer a pragmatic opportunity for early identification (screening) of ED risk indicators and related psychological distress, particularly during the menopausal transition. Thus, the aim of this study was to compare body dissatisfaction and ED risk indicators in older women attending dietary treatment versus those not following a dietary regimen. This cross-sectional study compared women aged ≥50 years without a prior ED diagnosis who were receiving medically supervised dietary treatment (DTG; n = 42) with peers not following any dietary regimen (NDG; n = 40) in Cádiz (Spain). Participants completed the Eating Disorder Inventory-3 Referral Form (EDI-3RF), AF-5 Self-Concept Questionnaire, List of Brief Symptoms (LBS-50), and the International Physical Activity Questionnaire (IPAQ) and underwent anthropometric assessment. Compared with those women in the NDG, those in the DTG had a higher body mass index (p = 0.002), higher drive for thinness (p < 0.001) and body dissatisfaction (p < 0.001), lower physical self-concept (p = 0.001), and higher total EDI-3RF scores (p < 0.001). Based on the EDI-3RF, 11.9% of the DTG met clinical referral criteria versus none in the NDG (p = 0.031). These findings indicate that, in this sample of women aged ≥ 50 years, women attending dietary care pathways exhibited a higher ED risk profile, higher psychopathological symptom levels, and lower physical self-concept than women not following a dietary regimen. Given the cross-sectional design, results should be interpreted as associations and may reflect pre-existing differences among women who enter dietary care; nonetheless, dietary care pathways may represent a practical opportunity to incorporate brief screening for body image concerns and ED risk indicators in older women.

26 February 2026

Flow diagram describing recruitment of participants to the study.

News & Conferences

Issues

Open for Submission

Editor's Choice

XFacebookLinkedIn
Women - ISSN 2673-4184